I spoke to Huntsman Foundation many months ago. I also, contacted the American Cancer Institute in D.C. They told me they couldn't comment on public companies but sounded interesting.
My advice is to help me keep hounding the www.thestreet.com biotech journalist. I've been successful getting them to write an article in the past and the stock blasted off.
Wittenberg has done NOTHING and he comes across as shady. Good time to send that guy packing - trust me on that.
Definitely HOLD ISIS. They have unbelievable technology that works on a genetic level unlike any other biotech company. They are working with RNA not DNA. They have air tight patents. Do not sell. This is a longterm play. You can always sell half that way you won't be disappointed either way. Good luck.
News 
Market Data 
Discover 
AI
